On ECHEMI
Home > Drugs > Arterial embolism
Arterial embolism
Arterial embolism refers to a blood clot or foreign matter that enters a blood vessel and becomes an embolus. As blood flow stops in a peripheral artery or visceral artery of similar smaller caliber, it causes blood flow obstruction.
Related Drugs
Pentoxifylline Sodium Chloride Injection
Indication: ① Cerebral blood circulation disorders such as transient cerebral ischemic attack, sequelae of stroke, and brain dysfunction caused by cerebral ischemia; ② Peripheral blood circulation disorders such as thromboembolic vasculitis, abdominal arterial blood circulation disorders, intermittent claudication or rest pain; ③ Inner ear circulation disorders such as sudden deafness, senile tinnitus and deafness; ④ Ocular blood circulation disorders such as diabetic retinal artery embolism.
Pentoxifylline Sodium Chloride Injection
Indication: ① Cerebral blood circulation disorders such as transient cerebral ischemic attack, sequelae of stroke, and brain dysfunction caused by cerebral ischemia; ② Peripheral blood circulation disorders such as thromboembolic vasculitis, abdominal arterial blood circulation disorders, intermittent claudication or rest pain; ③ Inner ear circulation disorders such as sudden deafness, senile tinnitus and deafness; ④ Ocular blood circulation disorders such as diabetic retinal artery embolism.
Pentoxifylline Sodium Chloride Injection
Indication: ① Cerebral blood circulation disorders such as transient cerebral ischemic attack, sequelae of stroke, and brain dysfunction caused by cerebral ischemia; ② Peripheral blood circulation disorders such as thromboembolic vasculitis, abdominal arterial blood circulation disorders, intermittent claudication or rest pain; ③ Inner ear circulation disorders such as sudden deafness, senile tinnitus and deafness; ④ Ocular blood circulation disorders such as diabetic retinal artery embolism.
Manufacturer:

Liaoning Hishen Liansheng Pharmaceutical Co., Ltd.

Pentoxifylline Sodium Chloride Injection
Indication: 1. Cerebral blood circulation disorders such as transient cerebral ischemic attack, sequelae of stroke, and brain dysfunction caused by cerebral ischemia; 2. Peripheral blood circulation disorders such as thromboembolic vasculitis, abdominal artery occlusion, intermittent claudication or rest pain; 3. Inner ear circulation disorders such as sudden deafness, senile tinnitus and deafness; 4. Ocular circulation disorders such as diabetic retinal artery embolism.
Manufacturer:

Cisen Pharmaceutical Co., Ltd.

Pentoxifylline Sodium Chloride Injection
Indication: ① Cerebral blood circulation disorders such as transient cerebral ischemic attack, sequelae of stroke, and brain dysfunction caused by cerebral ischemia; ② Peripheral blood circulation disorders such as thromboembolic vasculitis, abdominal arterial blood circulation disorders, intermittent claudication or rest pain; ③ Inner ear circulation disorders such as sudden deafness, senile tinnitus and deafness; ④ Ocular blood circulation disorders such as diabetic retinal artery embolism.
Manufacturer:

Jiangsu Shenlong Pharmaceutical Co., Ltd.

Pentoxifylline Sodium Chloride Injection
Indication: ① Cerebral blood circulation disorders such as transient cerebral ischemic attack, sequelae of stroke, and brain dysfunction caused by cerebral ischemia; ② Peripheral blood circulation disorders such as thromboembolic vasculitis, abdominal arterial blood circulation disorders, intermittent claudication or rest pain; ③ Inner ear circulation disorders such as sudden deafness, senile tinnitus and deafness; ④ Ocular blood circulation disorders such as diabetic retinal artery embolism.
Manufacturer:

Jiangsu Yabang Shengyuan Pharmaceutical Co., Ltd.

Pentoxifylline Sodium Chloride Injection
Indication: ① Cerebral blood circulation disorders such as transient cerebral ischemic attack, sequelae of stroke, and brain dysfunction caused by cerebral ischemia; ② Peripheral blood circulation disorders such as thromboembolic vasculitis, abdominal arterial blood circulation disorders, intermittent claudication or rest pain; ③ Inner ear circulation disorders such as sudden deafness, senile tinnitus and deafness; ④ Ocular blood circulation disorders such as diabetic retinal artery embolism.
Manufacturer:

Jiangsu Yabang Shengyuan Pharmaceutical Co., Ltd.

Pentoxifylline Sodium Chloride Injection
Indication: ① Cerebral blood circulation disorders such as transient cerebral ischemic attack, sequelae of stroke, and brain dysfunction caused by cerebral ischemia; ② Peripheral blood circulation disorders such as thromboembolic vasculitis, abdominal arterial blood circulation disorders, intermittent claudication or rest pain; ③ Inner ear circulation disorders such as sudden deafness, senile tinnitus and deafness; ④ Ocular blood circulation disorders such as diabetic retinal artery embolism.
Pentoxifylline Sodium Chloride Injection
Indication: ① Cerebral blood circulation disorders such as transient cerebral ischemic attack, sequelae of stroke, and brain dysfunction caused by cerebral ischemia; ② Peripheral blood circulation disorders such as thromboembolic vasculitis, abdominal arterial blood circulation disorders, intermittent claudication or rest pain; ③ Inner ear circulation disorders such as sudden deafness, senile tinnitus and deafness; ④ Ocular blood circulation disorders such as diabetic retinal artery embolism.
Pentoxifylline Sodium Chloride Injection
Indication: ① Cerebral blood circulation disorders such as transient cerebral ischemic attack, sequelae of stroke, and brain dysfunction caused by cerebral ischemia; ② Peripheral blood circulation disorders such as thromboembolic vasculitis, abdominal arterial blood circulation disorders, intermittent claudication or rest pain; ③ Inner ear circulation disorders such as sudden deafness, senile tinnitus and deafness; ④ Ocular blood circulation disorders such as diabetic retinal artery embolism.
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.